[1]
B14 / C15 Cancer Code Hierarchy Update
[149,3 KB]
From [scientific.thomson.com] Last viewed: 07.09.2006
B/C14-HC-Z Cancer Code Hierarchy Update
As part of the 2006 Manual Code update, Thomson Scientific has take the opportunity to organize the
current B/C14-H codes within disease-type hierarchies that will help to enhance searching of specific
cancer types, and allow for inclusion of further distinct cancer codes in the future.
All document records containing previous codes B/C14-H01C to B/C14-H01Z will be updated
according to the following code hierarchies, to eliminate the need for time-ranged searching. Codes
B/C14-H01M-Z will no longer be searchable.
B14-H01C
> Dermatological cancers (previously B/C14-H01W)
B14-H01D
> Endocrine cancers
B14-H01D1
>>
Breast cancers (previously B/C14-H01E)
B14-H01D2
>>
Thyroid cancers (previously B/C14-H01Z)
B14-H01E
> Gastrointestinal cancers
B14-H01E1 ...
[2]
CANCER TREATMENT
[97,5 KB]
From [www.dti.gov.uk] Last viewed: 07.09.2006
C U R I O S I T Y- D R I V E N R E S E A R C H
CANCER TREATMENT
What is it?
More people die from cancer in the UK
than from any other disease. It is the
major killer of both men and women in
the UK and one in three people will be
diagnosed with a form of cancer in their
lifetime. Since 1950 the number of
deaths from such things as heart
disease and strokes has declined
steeply, whereas the number of people
killed by cancer has remained
approximately the same. The number of
people contracting cancer increases
each year, though advances in
treatment have meant that mortality
rates are now falling. Modern physics
research is a key component of the medical care given to people with
cancer . Enabling early diagnoses and quick, effective and often
painless treatment, progress in medical physics is aiding this reduction
of mortality rates for many different ...
[3]
Cervical Cancer Information Sheet
[2879,5 KB]
From [www.icr.ac.uk] Last viewed: 07.09.2006
What you need to know about
CervicalCancer
Page 2
What is Cervical Cancer ?
Cervical cancer is cancer that
develops in the lining of the cervix.
The cervix is the canal that connects
the uterus (womb) to the vagina.
Each year, there are approximately
2,500 new cases of cervical cancer
in the UK.
Each year, just under 1,000 women
die from the disease in the UK.
Almost all cases of cervical cancer are
caused by the Human Papillomavirus
(HPV), a sexually transmitted virus
that infects and slowly changes the
cells of the cervix. Not all women with
HPV infection will go on to develop
cervical cancer , however almost
all women with cervical cancer are
infected with the virus. There are also
several other factors that are known to
affect your risk (see Risk Factors).
Risk Factors ...
[4]
21-1 - Cancer Trends During the 20th Century
[245,8 KB]
From [www.acnem.org] Last viewed: 07.09.2006
Reprinted from Journal of the Australasian College of Nutritional and Environmental Medicine - Vol 21 No 1 - April 2002 -
1
© 2002 ACNEM, Ö Hallberg & O Johansson
Cancer Trends During the 20th Century
Reprinted from . Journal of Australian College of Nutritional & Environmental Medicine Vol. 21 No. 1; April 2002: pages 3-8
®
Örjan Hallberg,
a
M.Sc. e.e., consultant and
Olle Johansson,
a
Assoc. Professor
Abstract
Purpose : To review development trends and possible relations
between different cancers in Sweden and in other countries to better
understand causing mechanisms.
Materials and methods : We used publicly available databases on
cancer incidence and mortality to highlight trends and trend breaks.
The data were used for correlation studies between different forms of
cancers as reported from different ...
[5]
Gynecologic Cancer
[73,9 KB]
From [www.cinj.org] Last viewed: 07.09.2006
September is Gynecologic Cancer Awareness Month
What Is Gynecologic Cancer ?
Gynecologic or female cancer is the growth and spread of cancer cells in the cervix, ovaries,
uterus, fallopian tubes, vagina, and vulva. These are also known as the reproductive organs.
fallopian tube
What Are the Key Statistics About Gynecologic Cancer ?
The American Cancer Society estimates that 77,250 women in the United States will be
diagnosed with cancers of the female reproductive organs this year. Cancer of the
endometrium, which is the lining of the uterus, is the most common gynecological cancer .
Ovarian cancer ranks fifth as a cause of cancer deaths among women and causes more deaths
than any other cancer of the female reproductive system. It is estimated that as many as
28,060 women will die in 2006 from gynecological cancers .
Who’s At Risk for Gynecologic Cancer ...
[6]
Cancer Resource Center Calendar
[194,9 KB]
From [www.uchospitals.edu] Last viewed: 07.09.2006
S
UN
M
ON
T
UE
W
ED
T
HU
F
RI
S
AT
1
2
3
4
5
6
7
8
9
1 0
1 1
1 2
1 3
1 4
1 5
1 6
1 7
1 8
1 9
2 0
2 1
2 2
2 3
2 4
2 5
2 6
2 7
2 8
2 9
3 0
3 1
August 2006
Organization
TheCancerResourceCenterisa Partnership of
TheUniversityofChicagoCancerResearchCenterand
The AmericanCancerSociety
Yourbusiness taglinehere.
Duchossois Center for Advanced
Medicine
5758 South Maryland Avenue
Chicago, IL 60637
Your Address Line 3
For information or to schedule
an appointment:
1-877-824-0660
cancerresources@uccrc.org
Hours: 9 AM to 5 PM
Organization
TheCancerResourceCenterisa ...
[7]
Nearly one in every three cancer deaths is due to lung cancer
[40,2 KB]
From [www.sts.org] Last viewed: 07.09.2006
Statistics Courtesy of the Lung Cancer Alliance
Nearly one in every three cancer deaths is due to lung cancer .
Lung cancer kills:
An average of 440 people a day, one every three minutes.
More than breast, prostate, colon, kidney, melanoma and liver cancers
combined.
Three times as many men as prostate cancer and twice as many women as
breast cancer .
More women than breast, cervical and ovarian cancers combined.
Non-smokers and former smokers now account for more than 60 percent of new
lung cancer cases, a fact that the public is just starting to become aware of.
50 percent of new cases in former smokers:
Tong L, Spitz MR, Fueger JJ, et al: “Lung Carcinoma in Former Smokers.” Cancer
78:1004-10, 1996.
Warner EE, Mulshine JL, “Lung Cancer Screening With Spiral CT: Toward a Working
Strategy.”Oncology (Williston Park). 2004 May; 18(5):564-75, ...
[8]
Cancer in Montana
[1992,7 KB]
From [www.dphhs.mt.gov] Last viewed: 07.09.2006
ARE YOU AT RISK FOR
COLORECTAL CANCER ?
S
tarting at age 50, men and women who are at average
risk of colorectal cancer should be screened regularly.
Nearly 90 percent of all cases of colorectal cancer are
diagnosed in people older than 50. Some men and
women are at higher risk of the disease and may need
to be tested earlier. Those at higher risk include:
• People with a personal or family history of benign
colorectal polyps.
• People with a personal or family history of colorectal cancer .
• People with a personal or family history of inflammatory
bowel disease — ulcerative colitis or Crohn’s.
• Men and women who use tobacco, drink too much alcohol,
are overweight or do not lead an active life.
• African Americans appear to be at higher risk for the disease
and are often diagnosed at a younger age — they may need
to begin screening at age 45.
March ...
[9]
IYH Skin Cancer E
[55,4 KB]
From [www.hc-sc.gc.ca] Last viewed: 07.09.2006
The Issue
Most cases of skin cancer are preventable.
You can reduce your risk of getting
skin cancer by taking some simple but
important steps.
Background
Skin plays a vital role in keeping us
healthy. It is the largest organ in our
body, and it protects us from potential
problems caused by such factors as
dehydration, the sun, bacterial infections,
and pollution. However, the skin’s ability
to protect us has limits. Various factors
can cause damage that cannot be
repaired. This is how skin cancer may
develop.
About Skin Cancer
There are three main types of skin cancer :
basal cell carcinoma, squamous cell
carcinoma, and malignant melanoma.
Most cases of skin cancer in Canada are
either basal or squamous cell carcinoma.
These skin cancers tends to develop
later in life on skin that has been
exposed repeatedly to the ...
[10]
CRD Report 27 - Systematic review of cancer waiting time audits
[625,4 KB]
From [www.york.ac.uk] Last viewed: 07.09.2006
Page 2
Page 3
A SYSTEMATIC REVIEW OF
CANCER WAITING TIME AUDITS
Ruth Lewis
Ros Collins
Adrian Flynn
Michael Emmans Dean
Lindsey Myers
Paul Wilson
Alison Eastwood
Centre for Reviews and Dissemination (CRD)
University of York
YO10 5DD, UK
February 2005
Page 4
ii
© 2005 Centre for Reviews and Dissemination, University of York
ISBN 1-900640-33 3
This report can be ordered from:
Publications Office, Centre for Reviews and
Dissemination, University of York, York YO10 5DD. Telephone 01904 321458; Facsimile:
01904 321035: email: crd-pub@york.ac.uk
Price £12.50
The Centre for Reviews and Dissemination is funded by the NHS Executive and the Health
Departments of Wales and Northern Ireland. The views expressed in this publication are ...
[11]
PROSTATE CANCER PATIENTS SOUGHT FOR DATABASE AS PART OF JOINT EFFORT
[38,8 KB]
From [www.cedars-sinai.edu] Last viewed: 07.09.2006
more
Media Contacts
Simi Singer – Cedars-Sinai
Keith Andre - Centinela
E-mail: simi.singer@cshs.org
Keith.Andre@centinelafreeman.com
Telephone: 310-423-7798
Telephone: 310-674-7050
PROSTATE CANCER PATIENTS SOUGHT FOR DATABASE AS PART OF JOINT EFFORT
AT CEDARS-SINAI MEDICAL CENTER AND CENTINELA FREEMAN REGIONAL MEDICAL
CENTER IN INGLEWOOD
Researchers at both medical centers hope data will help them understand the biology of
prostate cancer and lead to the development of future treatments.
(LOS ANGELES, CA) August 11, 2006 – Men with prostate cancer and their spouses/significant
others are being sought for a joint study being conducted by two Los Angeles-area medical
centers as part of a collaborative effort to better understand the genetics of the disease.
Prostate cancer is the most common form of cancer in men.
Cedars-Sinai Medical Center’s ...
[12]
Personalized therapy for breast cancer
[129,4 KB]
From [www.fraunhofer.de] Last viewed: 07.09.2006
2 Hub cancer centers tackle racial inequities
By Liz Kowalczyk, Globe Staff | July 29, 2006
Boston Medical Center is the place many of the city's minority residents go for care, but it has
lagged in buying some of the latest technology to diagnose and treat cancer . Dana-Farber
Cancer Institute offers the most advanced technology, but some minorities have viewed it as
unwelcoming.
Unequal access to high-quality cancer care is one reason blacks and Latinos in Boston and
nationwide suffer poorer health than whites, researchers say. But now, both of these Boston
institutions are tackling this problem.
Boston Medical Center will open a $119 million cancer center this fall where ``every piece of
equipment will be at the highest level in the city," said Peter Healy, vice president of professional
services, who is helping oversee the project. ``Our patients will have access to everything
available ...
[13]
BREAST CANCER - All Sections
[227,7 KB]
From [documents.cancer.org] Last viewed: 07.09.2006
BREAST CANCER - All Sections
BREAST CANCER
What Is Cancer ?
Cancer develops when cells in a part of the body begin to grow out of control. Although there are many kinds of
cancer , they all start because of out-of-control growth of abnormal cells.
Normal body cells grow, divide, and die in an orderly fashion. During the early years of a person's life, normal
cells divide more rapidly until the person becomes an adult. After that, cells in most parts of the body divide
only to replace worn-out or dying cells and to repair injuries.
Because cancer cells continue to grow and divide, they are different from normal cells. Instead of dying, they
outlive normal cells and continue to form new abnormal cells.
Cancer cells develop because of damage to DNA. This substance is in every cell and directs all its activities.
Most of the time when DNA becomes damaged the body is able to repair it. In cancer ...
[14]
Colorectal Cancer Factsheet
[44,2 KB]
From [www.hsrd.research.va.gov] Last viewed: 07.09.2006
Quality Enhancement Research Initiative
Colorectal cancer (CRC) is both a high vol-
ume and high-risk disease. CRC is the sec-
ond leading cause of cancer deaths,
accounts for approximately 11% of all new
cancer cases, and is the third most common
cancer among men and women in the
United States. The 5-year relative survival
rate is more than 90% for people whose
CRC is found and treated in Stage I, as
compared to 5% for people with Stage IV
disease. Unfortunately, fewer than 40% of
CRC cases are detected at an early stage.
Current CRC screening guidelines recom-
mend that veterans age 50 and older should
have a:
• Fecal Occult Blood Test (FOBT) series
once a year,
• Sigmoidoscopy or double contrast bari-
um enema (DCBE) every 5 years, or
• Colonoscopy every 10 years.
Best practice recommendations state that
all positive ...
[15]
26244 Cancer Plan Text
[1056,2 KB]
From [www.indianacancer.org] Last viewed: 07.09.2006
Indiana
Cancer
ControlPlan
ECCH@ECCK
Early detection
Primary prevention
Quality of life
Advocacy
Data
Treatment
Page 2
Indiana Cancer Consortium Mission
The Indiana Cancer Consortium is a statewide network of public and private
partnerships whose mission is to reduce the cancer burden in Indiana through the
development, implementation, and evaluation of a comprehensive plan that
addresses cancers across the continuum from prevention through palliation.
Dedication
This cancer control plan is dedicated to all the Hoosiers who have been affected
by cancer , and in memory of those who have died from the disease.
Cancer Control
Preventing the disease
Finding it early
Treating it promptly
Promoting quality living
Deciding with data
Advocating for change
...
[16]
BREAST CANCER
[397,0 KB]
From [wellnessconnection.wustl.edu] Last viewed: 07.09.2006
By Fern Carness, MPH, RN
T
here are countless, misleading myths regarding the nature of breast cancer .
For the sake of your health it’s important to know the difference between
myth and reality. Below are some of the common breast cancer myths, as well
as a dose of reality to help set the record straight.
Myth vs. Reality
MYTH:
Mammograms are 100 percent accurate.
REALITY: Few things in life are 100 percent accurate; the same is true for
mammograms. If you have a normal mammogram, but still feel a
lump, insist on further follow-up.
MYTH:
You’re not at risk for breast cancer if you don’t have a family history.
REALITY: More than 80 percent of newly diagnosed breast cancers are found in
women with NO family history. Regular screenings are important for
women of all ages.
MYTH:
Breast cancer is an older woman’s disease. ...
[17]
6801 Airport Boulevard • Mobile, Alabama 36608 • 251/633-1000 The ...
[38,6 KB]
From [images.pcmac.org] Last viewed: 07.09.2006
6801 Airport Boulevard • Mobile, Alabama 36608 • 251/633-1000
FOR IMMEDIATE RELEASE
July 27, 2006
CONTACTS: Michael King, Providence Hospital, 251-633-1367
Brigid Pace, M. D. Anderson Physicians Network
®
, 713-745-9607
The Cancer Center at Providence Announces Affiliation with
M. D. Anderson Cancer Manager
®
Program
Mobile, Ala. – Providence Hospital and the Cancer Center at Providence announced
today that they have formed an affiliation with M. D. Anderson Physicians Network
®
to further
enhance the level of cancer care available to eligible patients in Mobile County and surrounding
counties in southwest Alabama.
M. D. Anderson Physicians Network is an affiliate of The University of Texas
M. D. Anderson Cancer Center, a National Cancer Institute-designated comprehensive cancer
center that is consistently ...
[18]
Cancer Incidence and Mortality in the Industrial City of Sumgayit ...
[194,7 KB]
From [www.ijoeh.com] Last viewed: 07.09.2006
This study, the first environmental cancer study in Azer-
baijan, addressed concerns that residents of the indus-
trial city of Sumgayit have an increased cancer burden
as a consequence of intense occupational and environ-
mental pollution from industry. Vital statistics data
were used to calculate annual crude cancer incidence
and mortality rates for selected cancers and regions in
Azerbaijan for the years 1980–2000. Poisson regression
analysis of age- and sex-specific data from 1995–2000
demonstrates an increased risk for selected cancers in
Sumgayit relative to the rest of the country, as meas-
ured by adjusted rate ratios [aRR (95% CI))]: larynx
1.39 (1.04, 1.85), lung 1.67 (1.44, 1.92), bladder 2.49
(1.93, 3.22), and all sites 1.51 (1.43, 1.58). Sumgayit
appears to suffer from an increased cancer burden;
poor data quality and suspected underreporting, how-
ever, prevent accurate ...
[19]
RADIATION THERAPY for BREAST CANCER
[147,2 KB]
From [www.rtanswers.org] Last viewed: 07.09.2006
FACTS ABOUT
BREAST CANCER
Breast cancer is the most common type of cancer
in American women, according to the American
Cancer Society.
This year, nearly 213,000 women and 1,700 men will
learn they have breast cancer .
Another 62,000 women will learn they have nonin-
vasive (also called in situ) breast cancer .
Nearly 41,000 women and 500 men will die from
breast cancer this year.
Breast cancer can often be cured. About 80 percent
of all patients with breast cancer are free of the
disease 10 years after their diagnosis.
RADIATION THERAPY for
BREAST CANCER
Understanding Your
Treatment Options
THE AMERICAN SOCIETY FOR THERAPEUTIC
RADIOLOGY AND ONCOLOGY
Targeting Cancer Care
8280 Willow Oaks Corporate Drive
Suite 500
Fairfax, VA 22031
Phone: 1-800-962-7876 • 703-502-1550
Fax: 703-502-7852 ...
[20]
2 Hub cancer centers tackle racial inequities
[23,3 KB]
From [www.bumc.bu.edu] Last viewed: 07.09.2006
2 Hub cancer centers tackle racial inequities
By Liz Kowalczyk, Globe Staff | July 29, 2006
Boston Medical Center is the place many of the city's minority residents go for care, but it has
lagged in buying some of the latest technology to diagnose and treat cancer . Dana-Farber
Cancer Institute offers the most advanced technology, but some minorities have viewed it as
unwelcoming.
Unequal access to high-quality cancer care is one reason blacks and Latinos in Boston and
nationwide suffer poorer health than whites, researchers say. But now, both of these Boston
institutions are tackling this problem.
Boston Medical Center will open a $119 million cancer center this fall where ``every piece of
equipment will be at the highest level in the city," said Peter Healy, vice president of professional
services, who is helping oversee the project. ``Our patients will have access to everything
available ...
[21]
Lung Cancer pages mc-rlg-eg-071106.indd
[1414,8 KB]
From [www.cancercare.org] Last viewed: 07.09.2006
Lung Cancer
Treatment Update
Presented by
Richard J. Gralla, MD
New York Lung Cancer Alliance
Winfield A. Boerckel, MSW, MBA
Cancer Care
Find out about:
• Lung cancer basics
• Diagnostic tools
• Treatment options
• Your support team
Help and Hope
LUNG CANCER
Page 2
National Office
Cancer Care
275 Seventh Avenue
New York, NY 10001
Email: teled@cancercare.org
Services
Tel: 212-712-8080
1-800-813-HOPE (4673)
Administration
Tel: 212-712-8400
Fax: 212-712-8495
Email: info@cancercare.org
Website: www.cancercare.org
Cancer Care is a national nonprofit organization that provides free professional
support services to anyone affected by cancer : people with cancer , caregivers,
children, loved ones, and the bereaved. Cancer Care programs — including ...
[22]
COLORECTAL CANCER SCREENING The Colorado Clinical Guidelines ...
[87,5 KB]
From [www.coloradoguidelines.org] Last viewed: 07.09.2006
COLORECTAL CANCER SCREENING
Colorectal cancer is the second leading cause of cancer related deaths in the United
States. There is a 1 in 16 lifetime chance of developing colorectal cancer . The disease
strikes men and women in equal proportions. For those persons with a family history of
colorectal cancer , the risk may increase significantly. Colorectal cancer has a high
survival rate if detected early.
Screening Recommendations
1. All persons aged 50 or older should be screened for colorectal cancer with yearly fecal
occult blood testing (FOBT), a flexible sigmoidoscopy every five years, or both. The
American Cancer Society recommends flexible sigmoidoscopy and FOBT while the
U.S. Preventive Services Task Force recommends either or both tests for colorectal
cancer screening.
2. FOBT should be performed on three consecutive stool specimens. To correctly
perform FOBT, aspirin and non-steroidal ...
[23]
Prostate Cancer
[194,4 KB]
From [www.cancer.ca] Last viewed: 07.09.2006
F
R E Q U E N T LY
A
S K E D
Q
U E S T I O N S
WomensHealth.gov
1-800-994-9662
TDD: 1-888-220-5446
cer. Most cases occur in women over
Ovarian Cancer
the age of 50, but this disease can also
affect younger women. Ovarian cancer
causes more deaths than any other can-
Q: What is ovarian cancer ?
cer of the female reproductive system.
A:
Cancer is a disease in which certain
The sooner ovarian cancer is found and
treated, the better a woman’s chance for
body cells don’t function right, divide
recovery. But ovarian cancer is hard to
very fast, and produce too much tissue
detect early. Many times, women with
that forms a tumor . Ovarian cancer is
ovarian cancer have no symptoms or
cancer in the ovaries, the female repro-
just mild symptoms until ...
[24]
United States Cancer Statistics: 2002 Incidence and Mortality
[6807,3 KB]
From [www.cdc.gov] Last viewed: 07.09.2006
Issued by
The Association of Coloproctology of Great Britain and Ireland
The Association of Coloproctology of Great Britain & Ireland
at The Royal College of Surgeons of England
35-43 Lincoln’s Inn Fields, London, WC2A 3PE
Tel: + 44 (0)20 7973 0307, Fax: +444 (0)20 7430 9235
Email: acpgbi@asgbi.org.uk, Website: www.acpgbi.org.uk
GUIDELINES FOR THE MANAGEMENT
OF COLORECTAL CANCER
(2001)
Page 2
1. Expert Advisory Group
2. Background
i)
Colorectal Cancer in the UK
5
ii)
Purpose of Guidelines
5
iii)
Development of Guidelines
5
iv)
Validity of Guidelines.
6
v)
Review of Guidelines
6
3. Summary of Guidelines
7
4. Investigations
The process of referral and investigation
i)
Introduction
14
ii)
Clinical history ...
[25]
USCS - National Program of Cancer Registries - Scientific Working ...
[75,2 KB]
From [www.cdc.gov] Last viewed: 07.09.2006
Appendix B
National Program of Cancer Registries
Scientific Working Group Members
Mark E. Allen , MS, California Cancer Registry
Virginia C. Andrews , MSPH, South Carolina Central Cancer Registry
Vivien W. Chen, PhD, Louisiana Tumor Registry
Catherine N. Correa , PhD, MPH, Louisiana Tumor Registry
Susan T. Gershman , MS, MPH, PhD, CTR, Massachusetts Cancer Registry
Georgette G. Haydu , MS, Ohio Cancer Incidence Surveillance System
Jeannette Jackson-Thompson , PhD, MSPH, Missouri Cancer Registry
Alison T. Johnson , CTR, Vermont Cancer Registry
Amy Kahn , MS, CTR, New York State Cancer Registry
Karen L. Knight , MS, North Carolina Central Cancer Registry
Betsy A. Kohler , MPH, CTR, New Jersey State Cancer Registry
Sue Min Lai , PhD, MS, MBA, Kansas Cancer Registry
Jill A. MacKinnon , CTR, Florida Cancer Data System
Howard J. ...
[26]
Mammograms and Breast Cancer
[401,3 KB]
From [www.fda.gov] Last viewed: 07.09.2006
Department of Health and Human Services | Food and Drug Administration | 5600 Fishers Lane (HFI-40) | Rockville, MD 20857
Mammograms and Breast Cancer
What Is A Mammogram?
A mammogram is a special kind of X-ray of the breasts. Mammograms
are used to help find breast cancer early, when it can still be cured.
Mammograms are recommended for women older than 40, even if they
have no signs of breast cancer .
What About Younger Women?
Mammograms are also recommended for younger women who have
symptoms of breast cancer or who have a high risk of breast cancer .
Why Are Mammograms Important?
A mammogram can save your life. Mammograms can show tumors that
may be cancer long before they can be felt. Treating tumors when they are
still small makes curing cancer easier.
You usually need to go to a special clinic to get a mammogram. The FDA
inspects and certifies ...
[27]
USCS - Criteria for Reporting Age-Adjusted Cancer Incidence Rates ...
[140,2 KB]
From [www.cdc.gov] Last viewed: 07.09.2006
Appendix L
Criteria for Reporting Age-Adjusted Cancer
Incidence Rates for U.S. Census Regions
and Divisions
The annual age-adjusted cancer incidence rates for some
U.S. Census regions and divisions are not available
because the data from the cancer registries of some states
in those regions or divisions do not meet the eligibility
criteria for inclusion in this report. In contrast, the annual
age-adjusted cancer death rates are available for all states
in every Census region or division. However, the age-
adjusted incidence rate for Census regions or divisions in
which the data of less than 100% of the cancer registries
meet eligibility criteria can be estimated by assuming
the following: the incidence-to-mortality ratio for states
without eligible cancer registry data in that Census region
or division equals the incidence-to-mortality ratio for
states ...
[28]
2004 Science in Brief Fact Sheet: National Program of Cancer ...
[182,3 KB]
From [www.cdc.gov] Last viewed: 07.09.2006
SCIENCE
IN
BRIEF
:
Cancer Registries
For more information, please contact:
The Centers for Disease Control and Prevention • National Center for Chronic Disease Prevention and Health Promotion
Division of Cancer Prevention and Control • Mail Stop K-64, 4770 Buford Highway, NE • Atlanta, GA 30341-3717 • Phone (770) 488-4751
Fax (770) 488-4760 • Voice Information System 1 (888) 842-6355 • E-mail cancerinfo@cdc.gov • Web site http://www.cdc.gov/ cancer
Department of Health and Human Services
Centers for Disease Control and Prevention
2004/2005
FROM THE DIVISION OF CANCER PREVENTION AND CONTROL
National Program of Cancer Registries
Research and Evaluation Activities
Patterns of Care Study: Prostate, Colon,
Breast, and Ovarian Cancers
The Centers for Disease Control and Prevention’s
(CDC’s) National Program ...
[29]
Current Clinical Trials for Adults with Brain Tumor
[240,2 KB]
From [www.ucsfhealth.org] Last viewed: 07.09.2006
Recurrent Tumor ,
continued
A Phase II Trial of EMD 121974 for Recurrent Glioblastoma: a
Clinical Trial with Tissue Correlates of Response (NABTC 03-
02
A Phase II Trial of Poly ICLC in Patients with Recurrent
Anaplastic Glioma (NABTC 01-06)
A Multicenter Phase II Study of TP-38 in Those Patients With
Glioblastoma Multiforme [that has] Recurred or Progressed
After Previous Resection and Radiation Therapy and Are
Scheduled for Gross Total Resection
Phase II Trial of STI571 in Patients with Recurrent
Meningioma (NABTC 01-08)
Phase III Randomized Evaluation of Convection-Enhanced
Delivery of IL13-PEQQR Compared to Gliadel Wafer with
Survival Endpoint in Glioblastoma Multiforme Patients at First
Recurrence
A Biomarker and Phase II Study of GW 572016 in Recurrent
Malignant Glioma (NABTC 04-01)
Non-Chemotherapy Protocols
San Francisco Bay Area Adult ...
[30]
Follow-up after Primary Therapy for Endometrial Cancer: A Clinical ...
[104,1 KB]
From [www.cancercare.on.ca] Last viewed: 07.09.2006
PRACTICE GUIDELINE – page 1
Evidence-based Series #4-9: Section 1
Follow-up after Primary Therapy for Endometrial Cancer : A Clinical Practice
Guideline
M. Fung-Kee-Fung, J. Dodge, L. Elit, H. Lukka, A. Chambers, T. Oliver and the Gynecology Cancer
Disease Site Group
A Quality Initiative of the
Program in Evidence-based Care, Cancer Care Ontario.
Developed by the Provincial Gynecology Cancer Disease Site Group
Report Date: January 10, 2006
Question
What is the most appropriate strategy for the follow-up of patients with endometrial cancer who
are clinically disease-free after receiving potentially curative primary treatment? Specifically, do
differences in follow-up intervals, diagnostic interventions, clinical setting or specialty, influence patient
outcomes related to local or distant recurrence, survival, or quality of life?
Target Population ...